These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19858256)

  • 21. Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection.
    Goodwin SD; Gallis HA; Chow AT; Wong FA; Flor SC; Bartlett JA
    Antimicrob Agents Chemother; 1994 Apr; 38(4):799-804. PubMed ID: 8031049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA; Ambros LA; Landoni MF
    J Vet Pharmacol Ther; 2005 Aug; 28(4):363-9. PubMed ID: 16050816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered steady state pharmacokinetics of levofloxacin in adult cystic fibrosis patients receiving calcium carbonate.
    Pai MP; Allen SE; Amsden GW
    J Cyst Fibros; 2006 Aug; 5(3):153-7. PubMed ID: 16481224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
    Zhang J; Xu JF; Liu YB; Xiao ZK; Huang JA; Si B; Sun SH; Xia QM; Wu XJ; Cao GY; Shi YG; Zhang YY
    J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.
    Heine HS; Bassett J; Miller L; Hartings JM; Ivins BE; Pitt ML; Fritz D; Norris SL; Byrne WR
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1373-9. PubMed ID: 17296745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis.
    Peloquin CA; Hadad DJ; Molino LP; Palaci M; Boom WH; Dietze R; Johnson JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):852-7. PubMed ID: 18070980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics, urinary excretion and dosage regimen of levofloxacin following a single intramuscular administration in cross bred calves.
    Dumka VK; Srivastava AK
    J Vet Sci; 2006 Dec; 7(4):333-7. PubMed ID: 17106223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of intravenously administered levofloxacin in men and women.
    Overholser BR; Kays MB; Lagvankar S; Goldman M; Mueller BA; Sowinski KM
    Pharmacotherapy; 2005 Oct; 25(10):1310-8. PubMed ID: 16185174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzer.
    Sowinski KM; Lucksiri A; Kays MB; Scott MK; Mueller BA; Hamburger RJ
    Am J Kidney Dis; 2003 Aug; 42(2):342-9. PubMed ID: 12900817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition kinetics and dosage regimen of levofloxacin on concomitant administration with paracetamol in crossbred calves.
    Dumka VK
    J Vet Sci; 2007 Dec; 8(4):357-60. PubMed ID: 17993749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative bioavailability of two oral formulations of levofloxacin in healthy Mexican volunteers.
    M ; Flores-Murrieta FJ
    Int J Clin Pharmacol Ther; 2009 Apr; 47(4):283-6. PubMed ID: 19356395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of levofloxacin in Japanese quails (Coturnix japonica) following intravenous and oral administration.
    Aboubakr M
    Br Poult Sci; 2012; 53(6):784-9. PubMed ID: 23398423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and dynamic study of levofloxacin and rifampicin in bone and joint infections.
    Guillaume M; Garraffo R; Bensalem M; Janssen C; Bland S; Gaillat J; Bru JP
    Med Mal Infect; 2012 Sep; 42(9):414-20. PubMed ID: 22944286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence study of levofloxacin tablets in healthy Indian volunteers using HPLC.
    Das A; Mukherjee J; Dey G; Sarkar AK; Sahoo BK; Chakrabarty US; Nandi U; Pal TK
    Arzneimittelforschung; 2011; 61(1):61-5. PubMed ID: 21355447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation by Monte Carlo simulation of levofloxacin dosing for complicated urinary tract infections caused by Escherichia coli or Pseudomonas aeruginosa.
    Deguchi T; Seike K; Yasuda M; Matsumoto T
    J Infect Chemother; 2011 Oct; 17(5):726-30. PubMed ID: 21409530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax.
    Meyerhoff A; Albrecht R; Meyer JM; Dionne P; Higgins K; Murphy D
    Clin Infect Dis; 2004 Aug; 39(3):303-8. PubMed ID: 15306995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levofloxacin : a review of its use as a high-dose, short-course treatment for bacterial infection.
    Anderson VR; Perry CM
    Drugs; 2008; 68(4):535-65. PubMed ID: 18318569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [PK/PD profile and post-marketing surveillance of levofloxacin].
    Pea F
    Infez Med; 2009 Dec; 17 Suppl 5():13-22. PubMed ID: 20424532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.